Statistical significance for genomewide studies

Author(s): Storey JD, Tibshirani R

Abstract

With the increase in genomewide experiments and the sequencing of multiple genomes, the analysis of large data sets has become commonplace in biology. It is often the case that thousands of features in a genomewide data set are tested against some null hypothesis, where a number of features are expected to be significant. Here we propose an approach to measuring statistical significance in these genomewide studies based on the concept of the false discovery rate. This approach offers a sensible balance between the number of true and false positives that is automatically calibrated and easily interpreted. In doing so, a measure of statistical significance called the q value is associated with each tested feature. The q value is similar to the well known p value, except it is a measure of significance in terms of the false discovery rate rather than the false positive rate. Our approach avoids a flood of false positive results, while offering a more liberal criterion than what has been used in genome scans for linkage.

Similar Articles

Alzheimer's disease and the Amyloid-β Peptide

Author(s): Murphy MP, LeVine H

Adrenergic receptors in aging and Alzheimer's disease: Increased β2-Receptors in prefrontal cortex and hippocampus

Author(s): Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia aging study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Epac: Defining a new mechanism for cAMP action

Author(s): Gloerich M, Bos JL

G protein beta gamma subunits

Author(s): Clapham DE, Neer EJ

Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel

Author(s): Wickman KD, Iniguez-Lluhl JA, Davenport PA, Taussig R, Krapivinsky GB, et al.

G-protein beta Gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2

Author(s): Kim D, Lewis DL, Graziadei L, Neer EJ, Bar-Sagi D, et al.

The expanding roles of Gβγ subunits in G Protein-coupled receptor signaling and drug action

Author(s): Khan SM, Sleno R, Gora S, Zylbergold P, Laverdure JP, et al.

Binding of amyloid β peptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity

Author(s): Wang D, Govindaiah G, Liu R, De Arcangelis V, Cox CL, et al.

Alzheimer’s disease

Author(s): Burns A, Iliffe S

Alzheimer's disease

Author(s): Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al.

Brain amyloid-β oligomers in ageing and Alzheimer’s disease

Author(s): Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, et al.

The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia

Author(s): Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, et al.

Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease

Author(s): Ross JA, McGonigle P1, Van Bockstaele EJ

Mechanisms of phagocytosis in macrophages

Author(s): Aderem A, Underhill DM